Paul M Clement Selected Research

Paul M Clement Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 03/2009
10	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 03/2009
6	Glioma (Gliomas) 01/2022 - 11/2016
5	Neoplasm Metastasis (Metastasis) 06/2022 - 06/2016
5	Squamous Cell Carcinoma of Head and Neck 01/2022 - 05/2015
4	Fatigue 01/2022 - 05/2015
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 01/2020
3	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 11/2016
2	Brain Neoplasms (Brain Tumor) 01/2022 - 03/2009
2	Acne Vulgaris 10/2019 - 05/2015
2	Stomatitis 10/2019 - 05/2015
2	Exanthema (Rash) 10/2019 - 05/2015
2	Carcinoma (Carcinomatosis) 12/2016 - 06/2016
1	Carcinogenesis 01/2022
1	Meningioma (Meningiomas) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Central Nervous System Neoplasms 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Hypersensitivity (Allergy) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Necrosis 11/2019
1	Nausea 10/2019
1	Diarrhea 10/2019
1	Osteonecrosis (Kienbock's Disease) 04/2018
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2017
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2016
1	Chronic Hepatitis B 11/2016
1	Oligodendroglioma 11/2016
1	HIV Infections (HIV Infection) 11/2016
1	Infections 11/2016
1	Virus Diseases (Viral Diseases) 11/2016
1	Disease Progression 06/2016
1	Neutropenia 05/2015
1	Delirium 01/2014

Drug/Important Bio-Agent (IBA)

11	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 03/2009
5	Lomustine (CCNU)FDA Link 08/2021 - 11/2017
4	LigandsIBA 01/2022 - 12/2016
4	Bevacizumab (Avastin)FDA Link 01/2022 - 03/2015
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 03/2009
3	Peptide Receptors (Peptide Receptor)IBA 01/2022 - 01/2020
3	Radioisotopes (Radionuclides)IBA 01/2022 - 01/2020
3	depatuxizumab mafodotinIBA 08/2021 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 05/2015
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 12/2016
2	epidermal growth factor receptor VIIIIBA 01/2020 - 03/2009
2	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 10/2019 - 05/2015
2	AfatinibIBA 10/2019 - 05/2015
2	PlatinumIBA 01/2019 - 05/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 12/2016
2	Ifosfamide FDA LinkGeneric 01/2017 - 06/2016
1	Alkaline PhosphataseIBA 06/2022
1	Peptides (Polypeptides)IBA 06/2022
1	Serum AlbuminIBA 06/2022
1	larotrectinibIBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	TrabectedinIBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	TropomyosinIBA 01/2022
1	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2020
1	monomethylauristatin FIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	EpitopesIBA 01/2020
1	DOTA-Tyr(3)- 90Y-octreotideIBA 01/2020
1	NucleotidesIBA 01/2020
1	Ga(III)-DOTATOCIBA 01/2020
1	NVP-BKM120IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2019
1	durvalumabIBA 01/2019
1	Bone Density Conservation AgentsIBA 04/2018
1	Diphosphonates (Bisphosphonates)IBA 04/2018
1	Denosumab FDA Link 04/2018
1	Vincristine (Oncovin)FDA LinkGeneric 01/2017
1	Etoposide (VP 16)FDA LinkGeneric 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2016
1	Fluorouracil (Carac)FDA LinkGeneric 12/2016
1	MEHD7945AIBA 12/2016
1	taxaneIBA 12/2016
1	Trastuzumab (Herceptin)FDA Link 12/2016
1	human ERBB2 proteinIBA 12/2016
1	Nuclear Proteins (Protein, Nuclear)IBA 06/2016
1	Pharmaceutical PreparationsIBA 05/2015
1	Carmustine (FIVB)FDA Link 03/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2009

Therapy/Procedure

8	Therapeutics 06/2022 - 05/2015
8	Radiotherapy 01/2022 - 05/2015
8	Drug Therapy (Chemotherapy) 01/2021 - 06/2016
2	Precision Medicine 01/2022 - 10/2019
2	Palliative Care (Palliative Therapy) 06/2016 - 01/2014
1	Conformal Radiotherapy 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021
1	Neoadjuvant Therapy 01/2017
1	Oral Administration 11/2016